BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31052253)

  • 1. An Overview of Molecular Modeling for Drug Discovery with Specific Illustrative Examples of Applications.
    Aminpour M; Montemagno C; Tuszynski JA
    Molecules; 2019 Apr; 24(9):. PubMed ID: 31052253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Drug Discovery and Design using Computer-aided Molecular Modeling.
    Singh K; Bhushan B; Singh B
    Curr Comput Aided Drug Des; 2024; 20(5):697-710. PubMed ID: 37711101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational drug discovery.
    Ou-Yang SS; Lu JY; Kong XQ; Liang ZJ; Luo C; Jiang H
    Acta Pharmacol Sin; 2012 Sep; 33(9):1131-40. PubMed ID: 22922346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating molecular modelling methods to advance influenza A virus drug discovery.
    Patel H; Kukol A
    Drug Discov Today; 2021 Feb; 26(2):503-510. PubMed ID: 33220433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current insights into computer-aided immunotherapeutic design strategies.
    Cai Z; Zhang G; Zhang X; Liu Y; Fu X
    Int J Immunopathol Pharmacol; 2015 Sep; 28(3):278-85. PubMed ID: 26091813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Modeling Techniques and In-Silico Drug Discovery.
    Bagchi A
    Methods Mol Biol; 2024; 2719():1-11. PubMed ID: 37803109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein structure-based drug design: from docking to molecular dynamics.
    Śledź P; Caflisch A
    Curr Opin Struct Biol; 2018 Feb; 48():93-102. PubMed ID: 29149726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships.
    Naqvi AAT; Mohammad T; Hasan GM; Hassan MI
    Curr Top Med Chem; 2018; 18(20):1755-1768. PubMed ID: 30360721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances of In-Silico Modeling of Potent Antagonists for the Adenosine Receptors.
    Samanta PN; Kar S; Leszczynski J
    Curr Pharm Des; 2019; 25(7):750-773. PubMed ID: 30836910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
    Wang T; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations.
    Cournia Z; Allen B; Sherman W
    J Chem Inf Model; 2017 Dec; 57(12):2911-2937. PubMed ID: 29243483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the contribution of molecular topology to drug design and discovery.
    Gálvez J; García-Doménech R
    Curr Comput Aided Drug Des; 2010 Dec; 6(4):252-68. PubMed ID: 20883200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico drug discovery approaches on grid computing infrastructures.
    Wolf A; Shahid M; Kasam V; Ziegler W; Hofmann-Apitius M
    Curr Clin Pharmacol; 2010 Feb; 5(1):37-46. PubMed ID: 19642967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
    Morency LP; Gaudreault F; Najmanovich R
    Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Approaches for the Discovery of Human Proteasome Inhibitors: An Overview.
    Guedes RA; Serra P; Salvador JA; Guedes RC
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From laptop to benchtop to bedside: structure-based drug design on protein targets.
    Chen L; Morrow JK; Tran HT; Phatak SS; Du-Cuny L; Zhang S
    Curr Pharm Des; 2012; 18(9):1217-39. PubMed ID: 22316152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective.
    Saikia S; Bordoloi M
    Curr Drug Targets; 2019; 20(5):501-521. PubMed ID: 30360733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular simulation methods in drug discovery: a prospective outlook.
    Barril X; Luque FJ
    J Comput Aided Mol Des; 2012 Jan; 26(1):81-6. PubMed ID: 22160626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of
    Haider M; Chauhan A; Tariq S; Pathak DP; Siddiqui N; Ali S; Pottoo FH; Ali R
    Curr Top Med Chem; 2021; 21(11):995-1011. PubMed ID: 34061002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.